Oncology
 |
|
24 september 2022 20:39:32 |
| Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial (BMC Cancer) |
|
Tweet Recently, the combination of the programmed death-ligand 1 (PD-L1) inhibitor atezolizumab with first-line chemotherapy has demonstrated to improve outcome for patients with advanced small cell lung cancer (SCL... |
| 137 viewsCategory: Oncology |
 Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations (BMC Cancer)Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases (BMC Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
